Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07222163

Stuttering and Neuromodulation

Led by NYU Langone Health · Updated on 2025-10-29

16

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity and negative impact in adults who stutter. The study also aims to explore neuroplastic changes (i.e., regional activation and functional connectivity) resulting from combined tDCS + speech therapy.

CONDITIONS

Official Title

Stuttering and Neuromodulation

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • Diagnosis of developmental stuttering confirmed by a licensed speech-language pathologist
  • Mild-to-moderate or greater stuttering severity with a SSI-4 score of 20 or higher
  • English as a primary language
  • Right-handedness
  • Willing and able to attend all study sessions and follow study procedures
Not Eligible

You will not qualify if you...

  • History of neurological, psychiatric, or medical conditions contraindicated for tDCS
  • Currently taking medications that affect cortical excitability
  • History of seizures or epilepsy
  • Pregnant or planning to become pregnant during the study
  • Metal implants in the head (excluding dental work) or other contraindications to electrical brain stimulation
  • Skin disorder or sensitive area near stimulation sites

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NYU Langone Health

New York, New York, United States, 10016

Actively Recruiting

Loading map...

Research Team

E

Eric S. Jackson

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here